Literature DB >> 29978255

Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture.

Q-Y Wu1, F-L Yuan1, B Wang1, X Li2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29978255     DOI： 10.1007/s00198-018-4614-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  6 in total

1.  Bisphosphonates and atypical femoral fractures.

Authors:  Stuart L Silverman; Susan M Ott; Richard M Dell
Journal:  N Engl J Med       Date:  2010-09-09       Impact factor: 91.245

2.  Title of news article on zoledronic acid and bone density was misleading.

Authors:  Shyan Goh
Journal:  BMJ       Date:  2015-05-07

3.  Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway.

Authors:  X Li; J-X Ye; M-H Xu; M-D Zhao; F-L Yuan
Journal:  Osteoporos Int       Date:  2017-05-01       Impact factor: 4.507

4.  An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW).

Authors:  Daniel Prieto-Alhambra; Xavier Nogues; M Kassim Javaid; Allison Wyman; Nigel K Arden; Rafael Azagra; Cyrus Cooper; Jonathan D Adachi; Steven Boonen; Roland D Chapurlat; Juliet E Compston; Stephen H Gehlbach; Susan L Greenspan; Frederick H Hooven; J Coen Netelenbos; Johannes Pfeilschifter; Maurizio Rossini; Philip N Sambrook; Stuart Silverman; Ethel S Siris; Nelson B Watts; Adolfo Díez-Pérez
Journal:  Ann Rheum Dis       Date:  2012-06-23       Impact factor: 19.103

5.  Differences between the bisphosphonates for the prevention and treatment of osteoporosis.

Authors:  Andrew Grey; Ian R Reid
Journal:  Ther Clin Risk Manag       Date:  2006-03       Impact factor: 2.423

6.  Bisphosphonate use after clinical fracture and risk of new fracture.

Authors:  J Bergman; A Nordström; P Nordström
Journal:  Osteoporos Int       Date:  2018-02-03       Impact factor: 4.507
  6 in total
  1 in total

1.  Bisphosphonate use after clinical fracture and risk of new fracture: response to comments by Wu et al.

Authors:  J Bergman; A Nordström; P Nordström
Journal:  Osteoporos Int       Date:  2018-07-16       Impact factor: 4.507
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.